pubmed-article:10800798 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C0003641 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C0079189 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C0242599 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C0030685 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C0680255 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C0391871 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C1283071 | lld:lifeskim |
pubmed-article:10800798 | lifeskim:mentions | umls-concept:C1963578 | lld:lifeskim |
pubmed-article:10800798 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:10800798 | pubmed:dateCreated | 2000-5-19 | lld:pubmed |
pubmed-article:10800798 | pubmed:abstractText | Cardiopulmonary bypass (CPB) initiates a whole-body inflammatory response where complement and neutrophil activation and cytokine release play an important role. This prospective trial examined the effects of both heparin-coated circuits and aprotinin on the inflammatory processes during CPB, with respect to cytokine release and neutrophil activation. | lld:pubmed |
pubmed-article:10800798 | pubmed:language | eng | lld:pubmed |
pubmed-article:10800798 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10800798 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10800798 | pubmed:month | Apr | lld:pubmed |
pubmed-article:10800798 | pubmed:issn | 0003-4975 | lld:pubmed |
pubmed-article:10800798 | pubmed:author | pubmed-author:LimetRR | lld:pubmed |
pubmed-article:10800798 | pubmed:author | pubmed-author:LarbuissonRR | lld:pubmed |
pubmed-article:10800798 | pubmed:author | pubmed-author:PincemailJJ | lld:pubmed |
pubmed-article:10800798 | pubmed:author | pubmed-author:DefraigneJ... | lld:pubmed |
pubmed-article:10800798 | pubmed:author | pubmed-author:BlaffartFF | lld:pubmed |
pubmed-article:10800798 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10800798 | pubmed:volume | 69 | lld:pubmed |
pubmed-article:10800798 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10800798 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10800798 | pubmed:pagination | 1084-91 | lld:pubmed |
pubmed-article:10800798 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:meshHeading | pubmed-meshheading:10800798... | lld:pubmed |
pubmed-article:10800798 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10800798 | pubmed:articleTitle | Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration. | lld:pubmed |
pubmed-article:10800798 | pubmed:affiliation | Department of Cardiovascular Surgery, University Hospital of Liège, Belgium. jo.defraigne@chu.ulg.ac.be | lld:pubmed |
pubmed-article:10800798 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10800798 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10800798 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |